Hazard ratio of OS | 5-years OS rate | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Study | HR | 95% CI | I2 (%) | P | Study | OR | 95% CI | I2 | P | ||
LCI | UCI | LCI | UCI | ||||||||
0.65 | 0.57 | 0.74 | 46 |  < 0.001* | 1.890 | 1.623 | 2.198 | 49.8 |  < 0.001* | ||
Lai et al. [19] | 0.803 | 0.678 | 0.952 | 0 | 0.011 | Lai et al [19]Â | 1.605 | 1.182 | 2.179 | 39.3 | 0.002* |
Bliggenstorfer et al. [26]Â | 0.756 | 0.633 | 0.903 | 25.8 | 0.002 | Bliggenstorfer et al. [26] | 1.626 | 1.179 | 2.242 | 43 | 0.003* |
Naffouje et al. [29]Â | 0.812 | 0.716 | 0.921 | 0 | 0.001 | Naffouje et al. [29]Â | 1.543 | 1.159 | 2.053 | 34.9 | 0.003* |
Morris et al. [18]Â | 0.776 | 0.658 | 0.914 | 0 | 0.002 | Morris et al. [18]Â | 1.600 | 1.185 | 2.160 | 38.7 | 0.002* |
Gahagan et al. [31] | 0.790 | 0.694 | 0.9 | 0 |  < 0.001 | Gahagan et al. [31] | 1.546 | 1.175 | 2.033 | 34.9 | 0.002* |
Dossa et al. [35]Â | 0.774 | 0.648 | 0.925 | 13.9 | 0.005 | Dossa et al. [35] | 1.626 | 1.175 | 2.252 | 43 | 0.003* |
Polanco et al. [38] | 0.662 | 0.577 | 0.76 | 36 |  < 0.001 | Polanco et al. [38] | 1.616 | 1.176 | 2.222 | 41.1 | 0.003* |
Turner et al. [39]Â | 0.831 | 0.729 | 0.947 | 0 | 0.005 | Turner et al. [39]Â | 1.567 | 1.189 | 2.066 | 35.4 | 0.001* |
Shahab et al. [43]Â | 0.82 | 0.68 | 0.98 | 0 | 0.031 | Shahab et al. [43] | 1.650 | 1.168 | 2.331 | 52.1 | 0.004* |
Xu et al. [47]Â | 0.784 | 0.654 | 0.941 | 13.9 | 0.009 | Â | Â | Â | Â | Â | Â |